BioSig Technologies, Inc.

  • Home
  • About BioSig
    • Overview
    • Leadership
    • Bioelectronic Medicine
    • Partnerships
  • Pure EP
    • Our Solution
    • Publications
    • Physician Insights
  • Join Our Team
    • Join Our Team
    • Working at Biosig
    • Discover Your Potential
  • News & Media
    • Overview
    • Press Releases
    • BioSig in the News
    • Presentations
    • Events
    • CEO Blog
    • Newsletter
  • Investors
    • Investor Relations
    • Overview
    • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
    • Company Info
    • Profile
    • Presentations
    • Management Team
    • Contacts
    • FAQ
    • Financial Info
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
    • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
    • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • NeuroClear
  • Contact
Investors

Investors

  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Profile
    • Presentations
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Fact Sheet
    • Contacts
    • RSS News Feed

Press Releases

  • News / Events

  • Press Releases
  • IR Calendar
  • Email Alerts

BioSig Technologies to Present at the Proactive Investors One2One Virtual Event on August 4, 2020

July 30, 2020

BioSig Technologies to Participate in LD Micro’s Zooming with LD

July 23, 2020

ViralClear Announces Formation of Its Scientific Advisory Board

July 20, 2020

BioSig Technologies to Participate in the B Riley FBR Virtual Infectious Disease Summit

July 17, 2020

BioSig Technologies, Inc. Adopts Stockholder Rights Agreement

July 16, 2020

Phase II Human Trial of ViralClear's Anti-Viral for SARS-CoV-2 Coronavirus Underway at 4 Key Trial Sites

July 13, 2020

BioSig Submits Application to Systems for Award Management (SAM) with U.S. Government

July 10, 2020

ViralClear Pharmaceuticals partners with Albany Molecular Research Inc. on the manufacture of merimepodib active pharmaceutical ingredient development for the potential treatment of COVID-19

July 8, 2020

BioSig Technologies Inc. Appoints Tony Zook to the Board of Directors

July 1, 2020

BioSig Technologies, Inc Closes $17.5 Million Common Stock Offering

June 29, 2020
RSS
    • 1...
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    • ...30
    Award
    BioSig Technologies, Inc.
    Sign Up for BioSig Updates Contact Us
    Twitter linkedin Facebook
    © 2022 BioSig Technologies, Inc. All Rights Reserved.
    Privacy Policy Disclaimer Sitemap